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bDepartment of Radiology, L’Archet Hospital II, University of Nice-Sophia-Antipolis, Nice, FranceBackground: Because the retear rate after rotator cuff repairs remains high, methods to improve healing
are very much needed. Platelet-rich concentrates have been shown to enhance tenocyte proliferation and
promote extracellular matrix synthesis in vitro; however, their clinical benefit remains unclear. We hypoth-
esized that arthroscopic rotator cuff repair with leucocyte- and platelet-rich fibrin (L-PRF) results in better
clinical and radiographic outcome at 12 months of follow-up than without L-PRF.
Methods: Thirty-five patients were randomized to receive arthroscopic rotator cuff repair with L-PRF
locally applied to the repair site (L-PRFþ group, n ¼ 17) or without L-PRF (L-PRF group, n ¼ 18). Pre-
operative and postoperative clinical evaluation included the Subjective Shoulder Value, visual analog score
for pain, Simple Shoulder Test, and Constant-Murley score. The anatomic watertight healing, tendon thick-
ness, and tendon quality was evaluated using magnetic resonance arthrography at 12 months of follow-up.
Results: No complications were reported in either group. The mean Subjective Shoulder Value, Simple
Shoulder Test, and Constant-Murley scores increased from preoperatively to postoperatively, showing
no significant differences between the groups. Complete anatomic watertight healing was found in 11 of
17 in the L-PRFþ group and in 11 of 18 in the L-PRP group (P ¼ .73). The mean postoperative defect
size (214  130 mm2 in the L-PRFþ group vs 161  149 mm2 in the L-PRF group; P ¼ .391) and the
mean postoperative tendon quality according to Sugaya (L-PRFþ group: 3.0  1.4, L-PRF group:
3.0  0.9) were similar in both groups at 12 months of follow-up.
Conclusion: Arthroscopic rotator cuff repair with application of L-PRF yields no beneficial effect in clinical
outcome, anatomic healing rate,mean postoperative defect size, and tendon quality at 12months of follow-up.
Level of evidence: Level I, Randomized Controlled Trial, Treatment Study.
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L-PRF and late rotator cuff healing 3Despite developments in surgical techniques and suture
26,58
would result in an increased improvement in shoulder
materials, the failure rates of open, arthroscopic single-
row,6,24 and double-row repairs20,31 are still very high. The
incidence of failure of the tendon to heal after rotator cuff
repair is variable and is reported in up to 94%.24 Age is one
of the most significant predisposing factors, with signifi-
cantly higher failure rates in patients older than 65 years.6
A possible explanation for this is decreased vascularization
at the critical zone near the insertion of the rotator
cuff.41,50,52 Compared with healthier rotator cuff tissue,
degenerative rotator cuff tissue has a significantly less
vascular microcirculation.4 This decrease in the vascular
supply may predispose to the development of rotator cuff
tendinopathy53 and to a decreased healing rate after
attempted repair.19
Owing to the limited ability of the rotator cuff to heal,
several new strategies have been proposed, including bio-
logic augmentation of the ruptured rotator cuff with growth
factors and cytokines, gene therapy, and stem cell appli-
cation.10,32-34,48
Platelet-rich concentrates are classified according to the
presence of leucocytes and to the polymerization technique
of the fibrin.18 To our knowledge, 5 clinical studies have
been published using a leucocyte- and platelet-rich plasma
(L-PRP)36,48 and a leucocyte-poor or pure platelet-rich
fibrin (P-PRF)3,10,51 in rotator cuff repair.
Conversely, autologous leucocyte- and platelet-rich
fibrin (L-PRF), as described by Dohan et al,14-16 is a
bioactive component of whole blood that includes platelet
activation and fibrin polymerization. This simple and
open-access matrix can be produced by a standard
centrifugation procedure during the surgical operation in
less than 20 minutes. Its production is cost-effective
because it can be produced in a glass-coated tube
without any additives. Unlike PRP, L-PRF does not
dissolve quickly during the hours after application.57
Furthermore, due to the primary fibrin polymerization,
the stable matrix leads to an entrapment of growth fac-
tors that allows a continuous slow release of growth
factors for up to 28 days.57 In addition to the platelets,
the leucocytes produce a significant amount of growth
factors that are known to promote healing.17 The fibrin
matrix in the L-PRF also may have an effect on the
healing of the surrounding tissue by increasing neo-
vascularization.11 Our previous prospective randomized
pilot study demonstrated that the application of L-PRF
was technically feasible during arthroscopic rotator cuff
repair and yielded higher early vascularization at
6 weeks.
To date, however, there are no data from randomized
trials assessing the radiographic outcome and clinical
benefit of L-PRF augmentation in rotator cuff repair. This
study evaluated the clinical and radiographic outcome, with
and without application of L-PRF in rotator cuff repair, of
posterosuperior tears at 12 months postoperatively. We
hypothesized that biologic augmentation with L-PRFoutcome, a better anatomic healing rate, and increased
tendon thickness and quality.
Materials and methods
This prospective randomized blinded study assessed the clinical
and radiographic influence of intraoperative biologic augmenta-
tion of L-PRF in repair of chronic rotator cuff tendon tears.
Patient data
Thirty-five consecutive patients with chronic posterosuperior full-
thickness rotator cuff tears were treated between October 2008
and March 2009 with a primary arthroscopic repair by the senior
surgeon (P.B.) or under his direction.
Inclusion and exclusion criteria
Patients were included (1) if they had a posterosuperior chronic
full-thickness detachment limited to the supraspinatus and infra-
spinatus tendon with intact insertions of the subscapularis, (2) if
an arthroscopic double-row cuff repair with complete coverage of
the footprint could be performed, if necessary, after release of the
coracohumeral ligament from the coracoid and a supraglenoid
capsular release, and (3) if they were aged older than 55 years.
Also included were individuals with additional biceps pathology,
including delamination, tenosynovitis, inflammation, subluxation,
and dislocation.
Patients were excluded when the tear or the repair was only
partial thickness and when there had been a previous operation at
the rotator cuff. Diagnoses such as extension of the tear to the
subscapularis tendon, which requires surgical intervention, an
isolated subscapularis tear, workers’ compensation claims, or a
labral pathology amenable to surgical repair also resulted in the
exclusion of these patients.
Contraindications to arthroscopic cuff repair were upward
humeral migration (an acromiohumeral distance of <6 mm on the
anteroposterior radiographs with the shoulder in neutral rotation),
associated glenohumeral osteoarthritis, or severe muscle atrophy
or fatty infiltration (stage 3 or 4 according to the classification
system of Goutallier et al30) on a computed tomography arthro-
gram or magnetic resonance imaging (MRI) study.22 Patients were
definitively included in the study protocol after confirming the
diagnosis at the beginning of the surgery when the diagnostic
arthroscopy was performed.
Randomization
A block randomization was performed with a block size of 18
vs 17 patients.44 In the test group (L-PRFþ), we used an
arthroscopic transosseous equivalent double-row rotator cuff
repair with additional application of 4-folded L-PRF matrices in
between the bone and the tendon. In the control group (L-
PRF), we used the same rotator cuff repair, without the
application of L-PRF. Patients were blinded to the treatment
they had received. Clinical assessments, scores, and radio-
graphic evaluation were performed by independent observers
blinded to the treatment provided.
Figure 1 Preparation of 4 leucocyte platelet-rich fibrin clots.
Figure 2 The leukocyte platelet-rich fibrin clots (*) are placed
in between the tendon of the rotator cuff (+) and the bone (++).
Figure 3 The rotator cuff (+) is fixed on the lateral part of the
humerus (leukocyte platelet-rich fibrin clots are depicted in *).
4 M.A. Zumstein et al.Surgical technique and postoperative care
All patients underwent an arthroscopic mattress tension-band
transosseous equivalent double-row rotator cuff repair, as previ-
ously described.5 After bursectomy andmobilization of the cuff, the
dimension, shape, and reducibility of the tear was evaluated, and a
systematic release was performed if the cuff was retracted and
immobile. The goal was to allow a low-tension reduction of the
supraspinatus tendon to its anatomic position on the upper surface of
the greater tuberosity. Finally, the surgeon performed a debridement
of degenerative tendon using a basket biter or a shaver.
The soft tissue and cortical bone of the upper surface of the
greater tuberosity were abraded with a shaver and burr (Acro-
mionizer; Smith & Nephew Inc, Andover, MA, USA) to create an
even, bleeding cancellous bone bed, with avoidance of trough
formation, to promote tissue healing.
Medial double-loaded bioabsorbable suture anchors were
placed, and the sutures were passed through the medial part of the
tendon, including the often-delaminated deep layer of the tendon,
if present. The sutures were knotted in such a way that they fixed
the tendon to the medial part of the footprint, to avoid later
dislocation of the L-PRF medial to the medial row. In our previous
analysis, L-PRF showed 3 to 4 times lower growth factor content
than L-PRP (unpublished data). We therefore we prepared 4 L-
PRF clots to have results comparable to other studies.49,51
After 4 L-PRF clots were prepared according to the PRF
Process (Nice, France) and the modifications by Zumstein et al,57
the clots were folded, stacked, and sutured together with bio-
absorbable polyglactin 910 sutures (Vicryl; Johnson & Johnson,
Ethicon, Somerville, NJ, USA; Fig. 1).
To facilitate the application of the L-PRF clots, an 8.25-mm
threaded cannula (Smith & Nephew) was inserted through the
lateral portal. The stacked and sutured L-PRF conglomerate was
brought in between the tendon and the decorticated greater tu-
berosity and positioned optimally (Fig. 2). Then, the lateral row of
sutures was fixed at the lateral cortex of the humerus. This brought
the tendon back on the lateral part of the footprint and put
compression on the L-PRF clots between the tendon and the bone
(Fig. 3).
Although 2 anchors are sufficient for single supraspinatus
tears, we used 2 medial and 2 lateral anchors for supraspinatus and
infraspinatus tears. A subacromial decompression with acromio-
plasty was performed only if needed.
Shoulders were immobilized postoperatively for 4 weeks after
single-tendon tear repair and for 6 weeks after repair of massive
tears of the supraspinatus and infraspinatus using a sling in
adduction. Patients were encouraged to mobilize the elbow, wrist,
and hand immediately after. Patients were advised to perform
these exercises for 5 minutes at a time and 5 times a day for the
first 3 weeks. Parallel during the immobilization period, they were
sent to a physical therapist for passive motion exercises in the
plane of the scapula at 3 weeks. Further passive range of motion
and active-assisted range of motion exercises were allowed after
gradual weaning off the sling from 4 to 6 weeks after surgery. No
active motion was allowed for 6 weeks or until complete recovery
of passive motion had occurred. Hydrotherapy was strongly
encouraged. Patients began strengthening exercises after
3 months. Light sports activities were allowed after 3 months, and
full return to sports was allowed after 6 to 9 months, according to
individual recovery.Clinical assessment
Evaluation
Patients were assessed the day before the surgery and post-
operatively at 6 and 12 weeks and at l and 6 months until a final
follow-up of at least 12 months (range, 12-25 months).
Clinical outcome measures
Four outcome measures were used preoperatively and
postoperatively:
L-PRF and late rotator cuff healing 51. The patient’s subjective satisfaction with the clinical function
of the affected shoulder was rated as very satisfied, satisfied,
not satisfied, or disappointed.21,26,37,38,58
2. The Subjective Shoulder Value (SSV)26,29,37,38,58 is the pa-
tient’s estimated value of the involved shoulder as a per-
centage of an entirely healthy shoulder, with the latter being
100%.
3. The Simple Shoulder Test (SST)6,40 was used as a patient
based outcome score.
4. The absolute as well as the relative Constant and Murley
(CM) score12,13,29 was used as a clinical outcome score.
Clinical assessments and scores were performed by indepen-
dent observers blinded to the treatment provided.
Radiographic outcome measures
All patients underwent a standardized radiographic evaluation,
including anteroposterior and scapular lateral fluoroscopically
controlled views preoperatively and postoperatively at the latest
follow-up. The acromiohumeral distance8 and the acromion index
(a measure of the lateral extension of the acromion)45,58 were
measured as on a true anteroposterior shoulder radiograph. All
patients preoperatively had a computed tomography arthrogram
(28 patients) or MRI (7 patients). MRI scans of the shoulder were
obtained at the 12-month follow-up in every patient.
The extent of the rotator cuff tear was evaluated on the preop-
erative scans and confirmed by direct visualization with the
arthroscope in the lateral portal according to location, size, and
retraction. The location of the tear was classified into 6 segments or
sectors (A, B, C, D, E, or F), as according to Thomazeau et al,56 and
modified by Boileau et al.6 The mean tear area was calculated as
previously described26,37,38,58 by measuring the anteroposterior
diameter (base) and the mediolateral diameter (height) of the tear.
Retraction was graded, according to Patte,47 as 1 (not retracted), 2
(retracted to humeral head), or 3 (retracted to glenoid). Fatty infil-
tration of the rotator cuff muscles was assessed on a computed to-
mography arthrogram or onMRI scans andwas classified according
to Goutallier et al30 and Fuchs et al22 (grade 0¼ no fatty infiltration,
grade 1¼ some fatty streaks; grade 2¼more muscle than fat; grade
3 ¼ as much muscle as fat, or grade 4 ¼ less muscle than fat).
The integrity of the rotator cuff tendons was assessed post-
operatively using established MRI criteria.35,42,46 The diagnosis of
a full-thickness persistent tear was made when a fluid-equivalent
signal or nonvisualization of the supraspinatus or infraspinatus
tendon was found in 1 or more standard T2-weighted images, with
or without fat suppression. The size of the persistent defect in
nonhealed tears at the final follow-up assessment were compared
with the initial tear sizes found preoperatively by using the
maximal mediolateral and anteroposterior diameters, as previously
described.26,37,38,58
The rotator cuff insertion quality35,42 was postoperatively
classified into 0 (normal), 1 (scar tendinopathy), 2 (partial thin-
ning), 3 (localized transmural defect), and 4 (whole-tendon
defect), as well as according to Sugaya et al55 into 5 categories as
type I: sufficient thickness with homogenous low intensity; type
II: sufficient thickness with partial high intensity; type III: insuf-
ficient thickness without discontinuity (thinned cuff); type IV:
presence of minor discontinuity; and type V: presence of a major
discontinuity. Footprint coverage was classified into 4 categories:
100% coverage, >50% coverage, <50% coverage, and no
coverage of the footprint.The delamination of the supraspinatus tendon was evaluated in
the coronal T2-weighted MRI scans. Scans were assessed by 3
independent observers blinded to the treatment provided,
including a musculoskeletal radiologist and 2 fellowship-trained
shoulder surgeons. Definitive radiographic diagnosis was made in
consensus.
Statistics
Nonparametric statistical analyses were performed using SPSS
18.0 software (IBM Corp, Armonk, NY, USA). Data are presented
as the mean  the standard deviation of the mean. The mean
values were compared using the Mann-Whitney test for unpaired
groups and the Wilcoxon test for paired groups for continuous
variables and the c2 test or the Fisher exact test for categoric
variables. The Spearman correlation coefficient was used to test
quantitative relationships between variables. A difference of
P < .05 was considered to be statistically significant.
Power analysis
We determined the study sample size with a power analysis to
provide sufficient statistical power (80%) at an a level of 0.05.
With use of our previous data from the above-mentioned pilot
study, a power analysis provided a sample size of 17 patients per
group to detect a 10% difference in the CM score at the 12-month
follow-up, assuming a standard deviation of 10.9.Results
There were no intraoperative or postoperative complica-
tions or reoperations.
Baseline demographics
Thirty-five patients (18 men and 17 women) met the in-
clusion criteria and were randomized into 2 treatment
groups. The mean age was 65.3 years (range, 57-74 years).
There were no smokers in the study. The average duration
of the symptoms before surgery was 29 months (range, 3-
120 months). On the basis of the patient’s history, the tear
was associated with trauma in 9 shoulders in each group.
There were no significant differences in baseline charac-
teristics between the 2 groups (Table I).
Preoperatively, 9 patients in the L-PRFþ and 10 patients
in the L-PRF group had received at least 1 subacromial
injection of cortisone (range, 1-5; P ¼ .909), and 17 pa-
tients in the L-PRFþ group and 15 in the L-PRF group
had been preoperatively treated with medication or physical
therapy, or both.
The mean acromiohumeral distance, measured on the
preoperative anteroposterior radiograph in neutral rotation,
was 10 2 mm in the L-PRFþ group and 10 2 mm in the
L-PRF group. The acromion was curved (type II) in 16 and
hooked (type III) in 18 shoulders. The acromion index,45,58
was 0.70  0.064 for the L-PRFþ group and 0.72  0.071
Table I Comparison of preoperative clinical parameters
Parameter PRFþ group (n ¼ 17) PRF group (n ¼ 18) P value)
Gender distribution .505
Male, No. 10 8
Female, No. 7 10
Patients who received post-op
Infiltration, No. 9 10
Medication, No. 17 15
Age at surgery, mean (range) years 65 (58-74) 66 (55-73) .829
Follow-up, mean (range) months 14 (12-20) 15 (12-25) .817
Acromion index, mean  SD 0.70  0.064 0.72  0.071 .400
Acromiohumeral distance, mean  SD mm 10  2 10  2 .637
Supraspinatus tendon
Retractiony
None 2 1
To humeral head 12 12
To glenoid 3 5
Tear area, mean  SD mm2 322  180 445  421 .516
Location of the tear
Stagez
CD 4 5
CDE 4 7
BCD 1 2
BCDE 3 1
DE 1 1
PRFþ, platelet-rich fibrin augmentation; PRF, no platelet-rich fibrin augmentation; SD, standard deviation; CD, supraspinatus tear with infraspiantus
delamination; CDE, supraspinatus tear that extended in the subscapularis (delamination) and in the infraspinatus (delamination); BCD, supraspinatus and
infraspinatus tear; BCDE, supraspinatus, infraspinatus tear and teres minor tear; DE, supraspinatus tear that extended in the subscapularis (delamination).
) According to the Mann-Whitney test (P < .05 indicates statistical significance).
y According to Patte.47
z According to Thomazeau et al,56 and modified by Boileau et al.6
6 M.A. Zumstein et al.for the L-PRF group. There were no significant differences
between the 2 groups for the acromiohumeral distance
(P ¼ .637) and the acromion index (P ¼ .400).
In 4 patients of the L-PRFþ group and in 2 patients of
the L-PRF group, lesions affected only the supraspinatus
(stage D). The supraspinatus tear was associated with
infraspinatus delamination (stage CD) in 4 L-PRFþ
patients (5 in L-PRF group). In 4 cases of the L-
PRFþ group and in 7 in the L-PRF group, the supra-
spinatus tear was associated with anterior and posterior
delamination (stage CDE). The supraspinatus and infra-
spinatus, including also an anterior cleavage (stage BCD),
were involved in 1 tear of the L-PRFþ group and in 2 tears
of the L-PRF group. Three patients in the L-PRFþ group
and 1 patient in the L-PRF group had a complete tear of
the supraspinatus and infraspinatus tendon (BCDE) with
anterior (and posterior) delamination. In each group, the
supraspinatus tear extended anteriorly to the rotator inter-
val, leaving the long head of the biceps uncovered, or was
associated with subscapularis delamination or fraying
(stage DE) in 1 patient. The mean preoperative tear area
was 322  180 mm2 in the L-PRFþ group and
445  420 mm2 in the L-PRF group (P ¼ .533).Therewere also no differences inmean fatty infiltration of
the supraspinatus and infraspinatus muscles (supraspinatus:
1.44  0.70 in the L-PRFþ group vs 1.28  0.57 in the L-
PRF group, P ¼ .463; infraspinatus: 0.69  0.70 in the L-
PRFþ group vs 0.78 0.73 in the L-PRF group, P¼ .746).
There were no significant differences in the preoperative
clinical and radiographic subparameters between the 2
groups. Details are summarized in Table I.
Clinical outcomes
Overall satisfaction
At the mean 14 months of follow-up (range, 12-25 months),
13 patients of the L-PRFþ group rated the clinical result as
very satisfying and 4 as satisfying. The clinical result in the
L-PRF group was rated as very satisfying by 13 patients,
satisfying by 3, and not satisfying by 2. There were no
significant differences between the 2 groups (P ¼ .650).
Functional scores
Overall, there was a significant improvement of the SSVand
the SST from preoperatively to postoperatively (46% to 69%,
P¼.001; and 6.2 points to 9.8 points,P¼.01) in both groups.
Table II Comparison of clinical parameters preoperatively and at 12 months postoperatively
PRFþ group PRF group
Pre-op Post-op at
12 months
P value) Pre-op Post-op at
12 months
P value)
Subjective Shoulder Value, %y 46 88 .001 46 84 .001
Simple Shoulder Test, 1-12 5.4 10.7 .001 5.6 10.9 .001
Constant-Murley score
Absolute, pointsz 53 80 .001 55 80 .001
Relative, %x 70 105 .001 71 104 .001
VAS pain score, 1-10 points 6.3 13.9 .001 6.0 13.6 .001
Activity of daily living, points 9.1 18.4 .001 8.7 18.2 .001
Functional use of arm, points 30.4 36.3 .040 29.7 36.3 .010
Force, kg 7.5 12.5 .003 7.4 11.6 .003
Active mobility
Flexion,  156 167 .043 153 164 .014
External rotation,  39 46 .035 36 39 .264
Internal rotation, points 6.4 9.1 .001 5.9 7.8 .006
PRFþ, platelet-rich fibrin augmentation; PRF, no platelet-rich fibrin augmentation; VAS, visual analog scale.
) Wilcoxon signed rank test. Bold values indicate statistical significance (P < .05).
y Patient’s estimation of the operated shoulder in percentage compared with an entirely normal shoulder.
z Constant-Murley score in points.
x Relative Constant-Murley score in percentage of an age- and gender-related normal value.
L-PRF and late rotator cuff healing 7The absolute and the relative CM score increased signifi-
cantly from 53 12 points and 69% 15% preoperatively to
79 9 points and 104% 11% postoperatively (P¼ .001 for
both values) in the entire study population. All tested clinical
parameters improved significantly in all patients from pre-
operatively to postoperatively at the 12-month follow-up.
Details are reported in Table II.
The SSV, SST, and the absolute and relative CM score
and its’ subgroups were not significantly different between
the L-PRFþ and the L-PRF group at the 12-month
follow-up (Table III).
The surgical time in the L-PRFþ group was significantly
longer than in the L-PRF group (126  37 minutes vs
100  33 minutes, P ¼ .061).
Pain
Preoperatively, VAS pain scores for pain at night, pain on
motion, and average pain level were not different in the 2
groups. After surgery, all pain scores decreased with time
until the final follow-up in both groups. No significant
difference between the 2 groups was found for any VAS
pain measurement at any time point.Structural outcome: integrity and quality of the rotator
cuff insertion
The evaluation of the postoperative MRI scans showed no
significant differences in the overall anatomic healing rate
between the 2 groups, with 11 of 17 patients (65%) in the
L-PRFþ and 11 of 18 patients (62%) in the L-PRF group
(P ¼ .73). The mean defect size was 214  130 mm2 in the
L-PRFþ group and 161  149 mm2 in the L-PRF, withno significant difference between the 2 groups (P ¼ .391).
Ten of the 13 defects were smaller postoperatively
compared with the preoperative size.
A similar mean footprint coverage was achieved with a
1.89  1.17 in the L-PRFþ group and 1.94  0.94 in the L-
PRF group (P ¼ .660), which corresponds to coverage of
more than 50%.
Delamination in occurred in 4 patients the L-
PRFþ group and in 5 patients in the L-PRF group
(P ¼ .639). The mean postoperative rotator cuff quality,
according to Sugaya, was 3  1.41 for the L-PRFþ group
and 3  0.9 for the L-PRF group.
There was no significant increase of fatty infiltration in
the supraspinatus and infraspinatus muscles from preoper-
atively to postoperatively in either groups (supraspinatus:
1.44  0.70 to 1.76  0.83 in the L-PRFþ group, P ¼ .819;
infraspinatus: 0.69  0.70 to 1.18  0.73 in the L-PRF
group, P ¼ .144).
A postoperative comparison of the 2 groups revealed
significantlymore fatty infiltration of the supraspinatusmuscle
in the L-PRFþ group (1.76 0.83) than in the L-PRF group
(1.11  0.68; P ¼ .032). No difference in the amount of fatty
infiltration was found postoperatively in the infraspinatus
muscle between the 2 groups (1.18  0.73 in the L-
PRFþ group vs 0.76 0.57 in the L-PRF group, P¼ .114).Discussion
Tendon injuries are a significant source of pain and
disability. Most research on treating tendon injuries5-7,27,28
Table III Comparison of clinical and radiologic parameters preoperatively and at 3, 6, and 12 months postoperatively
Parameter Preoperatively 3 months
postoperatively
6 months
postoperatively
12 Months Postoperative
PRFþ
group
P
value)
PRF
group
PRFþ
group
P
value)
PRF
group
PRFþ
group
P
value)
PRF
group
PRFþ
group
P
value)
PRF
group
Subjective Shoulder Value,y % 46 .858 46 64.7 .684 63.6 78 .464 78.7 88 .932 84
Simple Shoulder Test 5.4 .851 5.6 9.06 .959 8.61 10.42 .113 13.78 10.7 .273 10.9
Constant-Murley score
Absolute,z points 53 .883 55 63 .757 62 72 .244 77 80 .546 80
Relative,x % 70 .807 71 81 .987 81 92 .032 99 105 .258 104
VAS pain score, 1-10 points 6.3 .883 6.0 11.9 .503 11.7 13.1 .986 12.7 13.9 .832 13.6
Activity of daily living, points 9.1 .103 8.7 15.6 .287 13.8 16.5 .274 17.9 18.4 .909 18.2
Functional use of arm, points 30.4 .908 29.7 29.2 .613 29.8 33 .155 36 36 .590 36
Force, kg 7.5 .708 7.4 6.9 .961 6.8 9.5 .873 10.1 12.5 .483 11.6
Active mobility
Flexion, 156 .935 167 137 .134 134 149 .012 161 153 .732 164
External rotation, 39 .287 46 31 .525 27 37 .873 38 36 .207 39
Internal rotation, points 6.4 .386 9.1 6.8 .424 6.3 7.6 .957 7.7 5.9 .089 7.8
Tendon qualityjj 2/6/3/2/4 0/3/8/6/1
Tendon homogeneity{ 1/12/4 0/13/5
Sugaya)) 2/6/3/2/4 0/7/5/5/1
Delaminationyy 13/4 13/5
Footprint coveragezz 1.88 1.94
SSP fatty infiltrationxx
Stage 0: no infiltration 1 1 6 6
Stage 1: some fatty streaks 8 11 8 11
Stage 2: more muscle than fat 8 6 3 1
Stage 3: as much muscle as fat 0 0 0 0
Stage 4: less muscle than fat 0 0 0 0
ISP fatty infiltrationxx
Stage 0: no infiltration 7 7 3 5
Stage 1: some fatty streaks 8 8 8 12
Stage 2: more muscle than fat 2 3 6 1
Stage 3: as much muscle as fat 0 0 0 0
Stage 4: less muscle than fat 0 0 0 0
ISP, infraspinatus; PRFþ, platelet-rich fibrin augmentation; PRF, no platelet-rich fibrin augmentation; SSP, supraspinatus; VAS, visual analog scale.
) According to the Mann-Whitney test. Bold values indicate statistical significance (P < .05).
y Patient’s estimation of the operated shoulder in percentage compared with an entirely normal shoulder.
z Constant-Murley score in points.
x Relative Constant-Murley score in percentage of an age- and gender-related normal value.
k 0, normal; 1, scar tendinopathy; 2, partial thinning; 3, localized transmural defect; 4, whole-tendon defect.
{ 0, normal; 1, inhomogeneous; 2, delaminated.
)) Classification according to Sugaya et al55 into 5 categories (I, sufficient thickness with homogenously low intensity; II, sufficient thickness with
partial high intensity; III, insufficient thickness without discontinuity (thinned cuff); IV, presence of minor discontinuity; V, presence of a major
discontinuity).
yy 0, no delamination; 1, delamination.
zz 4 categories: 1, 100% coverage; 2, >50% coverage; 3, <50% coverage; 4, no coverage.
xx According to Goutallier et al30 and Fuchs et al.22
8 M.A. Zumstein et al.indicates that biologic properties, such as tissue composi-
tion23,25,39,43 and vascularization1,2 of the aging tendon, are
key determinants, and it seems that the healing rate cannot
be improved with mechanical augmentation alone.
Recently, attention has turned to the biology of tendon
healing as a means to improve the outcome of such injuries.
Biologic augmentation using growth factors may have a
potential benefit in rotator cuff surgery with, among otherthings, an increase in vascularization, which may improve
the watertight healing rate.2,9 However, research in this
field is still inconclusive, and that there is a clinical benefit
has not been sufficiently demonstrated.
Platelet concentrates for musculoskeletal injuries are
innovative tools for regenerative medicine. However, many
different products are available, and yet, little is known
about the biologic properties of these products. There are 4
L-PRF and late rotator cuff healing 9main families of platelet concentrates, each with different
fibrin architecture and cellular content.18 P-PRP and L-PRP
are platelet suspensions, respectively, without and with
leukocytes, that can be used as liquid injectable prepara-
tions. In an open surgical site, these products can be acti-
vated into a fibrin gel that offers additional local
antihemorrhagic and sealing properties. Conversely, P-PRF
and L-PRF are solid fibrin-based bioactive healing bio-
materials, respectively, without and with leukocytes. The
advantage of L-PRF as a solid scaffold for the long-term
delivery of growth factors57 is a innovative approach in
tissue engineering of rotator cuff repairs.
The main goal of this study was to investigate the effect
of the biologic augmentation with L-PRF on the clinical
outcome at a mean follow-up of 14 months postoperatively.
The secondary end point was to investigate the radiologic
outcome of this treatment. This is the first prospective,
randomized, double-blinded, controlled study to investigate
the effect of L-PRF augmentation during arthroscopic ro-
tator cuff repair. The absolute and relative CM score, the
SSV, and SST improved significantly from preoperatively
to postoperatively but failed to show any differences be-
tween the L-PRFþ and L-PRF group at all time points.
Furthermore, no significant improvement in structural
integrity and tissue quality was evident, and overall non-
healing rates were not significantly different between the L-
PRFþ and the L-PRF groups.
To our knowledge, there are no studies in which rotator
cuff repairs have been augmented with L-PRF; therefore a
comparison with other studies that were using the same L-
PRF preparation is not possible to date. Several studies,
though, used other forms of autologous platelet-rich con-
centrates for rotator cuff augmentation. Castricini et al10
showed that augmentation with leucocyte-poor or P-PRF
did not provide superior clinical and structural outcomes
compared with a control group. Rodeo et al51 reported
similar short-term results using also platelet-rich fibrin
matrix as a leucocyte-poor or P-PRF in a prospective ran-
domized study with 79 patients. Similar results could be
found using PRP.19,36
In contrast, in a case-control study Barber et al36 showed
that the augmentation of the rotator cuff with leucocyte-poor
or P-PRF results in lower healing defect rates without a
clinical difference in outcome measures. Interestingly, the
authors reported a 60% nonhealing rate in the control group,
which is relatively high in a mixed tear size group. In another
nonrandomized single group study with 14 patients, autolo-
gous L-PRP augmentation for arthroscopic rotator cuff repair
provided good clinical results.48,49 Comparing these studies’
resultswith our own results, 2 aspectsmust be considered: the
amount of growth factors released over time and the
manufacturing process of the different platelet-rich prepa-
rations. Even if the preparation techniques of platelets and
leucocyte concentrates are standardized, there is an immense
interindividual variation in the quantity and quality of
platelets and growth factors released between differentpatients, as shown by different authors.17,57 In addition,
different platelet-rich concentrates are prepared in different
manners, which leads to a wide variation in platelet activa-
tion, growth factor release, and reaction with the cells of the
tendon and bone. In this field, additional research is needed to
understand the cause for the immense variability in platelet
and growth factor release. A weakness of our study is the
absence of information about the number or platelets in the
applied L-PRF. However, we reported in previous studies the
amount of platelets and growth factor release with this pro-
tocol over time.57
Previous studies suggest that there is a difference in the
clinical outcome between nonhealed and healed rotator cuff
repairs.6,54,58 We found a slightly better patient satisfaction
in the healed rotator cuffs, but the difference was without
significance.
In our study, the use of autologous platelet-derived
growth factors results in longer surgical time, is more
expensive, and may be technically more demanding.
However no local or systemic infection or other compli-
cations occurred with the intraoperative use of L-PRF. This
is in accordance with previous studies.36,48,51
This study has some limitations, including that (1) we
did not assess the number of patients who were eligible and
recruited from our clinic and recorded the dropouts due to
the exclusion criteria, (2) we had a small sample size
determined by the power calculation according to the CM
score as the primary outcome point in our previous studies
with a potential type 2 error; and (3) we had still not a
complete characterization of the L-PRFs used in this study.
However, because we analyzed the different protocols
previously57 and were able to detect a slow release over
time, we do not think that this influenced the data.ConclusionOur study does not support the use of autologous L-PRF
for augmentation of a double-row repair of a rotator cuff.
Compared with the significantly shorter and technically
less demanding double-row repair without augmenta-
tion, we did not find an improved clinical or structural
outcome. Because there is an immense heterogeneity of
platelet-rich concentrate preparations, it is possible that
other preparations may be more effective.AcknowledgmentsThis study was funded by the European Society for
Surgery of the Shoulder and Elbow with the Societe
Europeenne pour la Chirurgie de l’Epaule et du Coude
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